SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

J C Penney Corp. Inc. – ‘3’ for 11/23/98 re: Genovese Drug Stores Inc.

As of:  Thursday, 12/3/98   ·   For:  11/23/98   ·   Accession #:  77182-98-31   ·   File #:  1-07623

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer

12/03/98  Penney J C Co. Inc.               3          10% Owner   1:7K   Genovese Drug Stores Inc.

Initial Statement of Beneficial Ownership of Securities by an Insider   —   Form 3   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 3           Initial Statement of Beneficial Ownership of           4     14K 
                Securities by an Insider                                         

31st Page of 4TOCTopPreviousNextBottomJust 1st
 

[Enlarge/Download Table]
32nd Page of 4TOC1stPreviousNextBottomJust 2nd
- -------- FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION - -------- Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - ---------------------------------------------------------------- 1. Name and Address of Reporting Person J. C. Penney Company, Inc. - ---------------------------------------------------------------- (Last) (First) (Middle) 6501 Legacy Drive - ---------------------------------------------------------------- (Street) Plano, TX 75024-3698 - ---------------------------------------------------------------- (City) (State) (Zip) *If the Form is filed by more than one Reporting Person, see Instruction 5(b)(v). - ---------------------------------------------------------------- 2. Date of Event Requiring Statement (Month/Day/Year) November 23, 1998 - ---------------------------------------------------------------- 3. IRS or Social Security Number of Reporting Person (Voluntary) - ---------------------------------------------------------------- 4. Issuer Name and Ticker or Trading Symbol Genovese Drug Stores, Inc. GDXA - ---------------------------------------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) - ---------------------------------------------------------------- 6. If Amendment, Date of Original (Month/Day/Year) - ---------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) __X_ Form filed by One Reporting Person ____ Form filed by More than One Reporting Person
33rd Page of 4TOC1stPreviousNextBottomJust 3rd
________________________________________________________________________________________________________________________________ Table I -- Non-Derivative Securities Beneficially Owned | ________________________________________________________________________________________________________________________________| 1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect | (Instr. 4) | Securities | Form: | Beneficial Ownership | | Beneficially | Direct(D) or | (Instr. 5) | | Owned | Indirect(I) | | (Instr. 4) (Instr. 5) | ________________________________________________________________________________________________________________________________|
No Shares Owned (1) | | | | --------------------------------------------------------------------------------------------------------------------------------| ________________________________________________________________________________________________________________________________|
3Last Page of 4TOC1stPreviousNextBottomJust 4th
________________________________________________________________________________________________________________________________ FORM 3 (CONTINUED) TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, | CONVERTIBLE SECURITIES) | --------------------------------------------------------------------------------------------------------------------------------| | 1. Title of Derivative 2. Date Exer- 3. Title and Amount of 4. Conversion 5. Owner- 6. Nature of Indirect | Security (Instr. 4) cisable and Securities Underlying or Exercise ship Beneficial | Expiration Derivative Security Price of Form of Ownership | Date (Instr. 4) Derivative Derivative (Instr. 5) | (Month/Day/ Security Security: | Year) Direct | ------------------------------------------------------------ (D) or | Date Expira- Amount Indirect | Exer- tion or (I) | cisable Date Title Number (Instr. 5) | of | Shares | ________________________________________________________________________________________________________________________________| <CAPTION Explanation of Responses: (1) The reporting person may be deemed the beneficial owner of greater than 10% of the shares of Common Stock, par value $1.00 per share, of Genovese Drug Stores, Inc. by virtue of the reporting person's shared voting power of such shares. However, no such shares have been reported on this Form 3 because the reporting person has no pecuniary interest in any of such shares. J. C. Penney Company, Inc. By: /s/ Donald A. McKay December 3, 1998 ----------------------------- ---------------- **Intentional misstatements or omissions of facts constitute Executive Vice President Date Federal Criminal Violations. **Signature of Reporting Person See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘3’ Filing    Date First  Last      Other Filings
Filed on:12/3/9843,  SC 13D
For Period end:11/23/9823,  8-K
 List all Filings 
Top
Filing Submission 0000077182-98-000031   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 1:15:22.1pm ET